Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination"

Affiliations

¹ Division of Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
² School of Pharmacy, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
³ Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Comment

Hiep Phan et al. Inflamm Bowel Dis. 2023.

. 2023 Mar 1;29(3):e8-e9.

doi: 10.1093/ibd/izad006.

¹ Division of Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
² School of Pharmacy, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
³ Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

No abstract available

Comment on

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
Caldera F, Farraye FA, Necela BM, Cogen D, Saha S, Wald A, Daoud ND, Chun K, Grimes I, Lutz M, Van Helden SR, Swift MD, Virk A, Bharucha AE, Patel TC, Gores GJ, Chumsri S, Hayney MS, Knutson KL. Caldera F, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):1202-1209. doi: 10.1093/ibd/izac193. Inflamm Bowel Dis. 2023. PMID: 36103273 Free PMC article.
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.
Mungmunpuntipantip R, Wiwanitkit V. Mungmunpuntipantip R, et al. Inflamm Bowel Dis. 2023 Mar 1;29(3):e7. doi: 10.1093/ibd/izac257. Inflamm Bowel Dis. 2023. PMID: 36579751 No abstract available.